Anne Wojcicki's nonprofit is set to purchase all significant assets of the bankrupt genetic testing company, 23andMe, for ...

Ahead of a sale, only 15% of 23andMe's user base has deleted accounts. Do people not care, or are they just unaware? For ...

A biotech future built on data: Regeneron’s acquisition of 23andMe blurs the line between pharmaceutical innovation and genetic surveillance. Unsplash+ “We are pleased to have reached a ...

Court documents show that the second-highest bid—$146 million—came from a nonprofit research institute founded by Anne Wojcicki, 23andMe’s cofounder and former CEO. As part of the sale ...

In March 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan. Its co-founder and CEO Anne Wojcicki also resigned from the top post, ...

Court filings give insight into why shooting suspect Louis Mangione might have targeted the UnitedHealthcare executive: "It checks every box." In other news: Hospital construction trends include AI; ...

The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.

23andMe struck a deal last month with Regeneron Pharmaceuticals Inc., but Wojcicki complained about the bidding process, ...

Nice 23andMe sale hearing ya got there — shame if something happened to it, say attorneys for co-founder and former CEO who plan an objection to 23andMe's sale to Regeneron 23andMe deal details ...